Annual FCF
-$3.83 B
-$8.41 B-183.50%
31 December 2023
Summary:
Moderna annual free cash flow is currently -$3.83 billion, with the most recent change of -$8.41 billion (-183.50%) on 31 December 2023. During the last 3 years, it has fallen by -$5.78 billion (-295.25%). MRNA annual FCF is now -128.68% below its all-time high of $13.34 billion, reached on 31 December 2021.MRNA Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$1.72 B
-$261.00 M-17.93%
30 September 2024
Summary:
Moderna quarterly free cash flow is currently -$1.72 billion, with the most recent change of -$261.00 million (-17.93%) on 30 September 2024. Over the past year, it has increased by +$23.00 million (+1.32%). MRNA quarterly FCF is now -142.57% below its all-time high of $4.03 billion, reached on 30 June 2021.MRNA Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$3.96 B
+$23.00 M+0.58%
30 September 2024
Summary:
Moderna TTM free cash flow is currently -$3.96 billion, with the most recent change of +$23.00 million (+0.58%) on 30 September 2024. Over the past year, it has dropped by -$1.30 billion (-48.89%). MRNA TTM FCF is now -129.66% below its all-time high of $13.34 billion, reached on 31 December 2021.MRNA TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MRNA Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -183.5% | +1.3% | -48.9% |
| 3 y3 years | -295.3% | -154.0% | -134.7% |
| 5 y5 years | -776.0% | -1408.7% | -708.2% |
MRNA Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -128.7% | at low | -153.8% | +1.3% | -129.7% | +0.6% |
| 5 y | 5 years | -128.7% | at low | -142.6% | +1.3% | -129.7% | +0.6% |
| alltime | all time | -128.7% | at low | -142.6% | +1.3% | -129.7% | +0.6% |
Moderna Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$1.72 B(+17.9%) | -$3.96 B(-0.6%) |
| June 2024 | - | -$1.46 B(+22.9%) | -$3.98 B(+8.4%) |
| Mar 2024 | - | -$1.19 B(-394.8%) | -$3.67 B(-4.0%) |
| Dec 2023 | -$3.83 B(-183.5%) | $402.00 M(-123.1%) | -$3.83 B(+44.0%) |
| Sept 2023 | - | -$1.74 B(+51.4%) | -$2.66 B(+252.4%) |
| June 2023 | - | -$1.15 B(-14.1%) | -$754.00 M(-223.2%) |
| Mar 2023 | - | -$1.34 B(-185.2%) | $612.00 M(-86.6%) |
| Dec 2022 | $4.58 B(-65.6%) | $1.57 B(+863.2%) | $4.58 B(-26.1%) |
| Sept 2022 | - | $163.00 M(-24.9%) | $6.20 B(-32.7%) |
| June 2022 | - | $217.00 M(-91.8%) | $9.21 B(-29.3%) |
| Mar 2022 | - | $2.63 B(-17.5%) | $13.03 B(-2.3%) |
| Dec 2021 | $13.34 B(+580.8%) | $3.19 B(+0.4%) | $13.34 B(+17.1%) |
| Sept 2021 | - | $3.18 B(-21.2%) | $11.39 B(+25.4%) |
| June 2021 | - | $4.03 B(+37.4%) | $9.08 B(+81.4%) |
| Mar 2021 | - | $2.94 B(+136.8%) | $5.01 B(+155.6%) |
| Dec 2020 | $1.96 B(-499.0%) | $1.24 B(+41.9%) | $1.96 B(+219.7%) |
| Sept 2020 | - | $874.00 M(-2132.6%) | $612.84 M(-263.4%) |
| June 2020 | - | -$43.00 M(-61.6%) | -$374.97 M(-16.9%) |
| Mar 2020 | - | -$112.00 M(+5.5%) | -$451.14 M(-8.1%) |
| Dec 2019 | -$491.00 M(+12.5%) | -$106.16 M(-6.7%) | -$491.00 M(+0.3%) |
| Sept 2019 | - | -$113.80 M(-4.5%) | -$489.50 M(+1.5%) |
| June 2019 | - | -$119.17 M(-21.5%) | -$482.04 M(+8.3%) |
| Mar 2019 | - | -$151.86 M(+45.1%) | -$445.20 M(+2.0%) |
| Dec 2018 | -$436.63 M(+12.0%) | -$104.66 M(-1.6%) | -$436.63 M(+31.4%) |
| Sept 2018 | - | -$106.35 M(+29.2%) | -$332.31 M(+46.9%) |
| June 2018 | - | -$82.33 M(-42.5%) | -$226.23 M(+56.5%) |
| Mar 2018 | - | -$143.29 M(>+9900.0%) | -$144.57 M(+8738.2%) |
| Dec 2017 | -$389.88 M(-1260.7%) | -$337.50 K(+27.0%) | -$1.64 M(+7.3%) |
| Sept 2017 | - | -$265.70 K(-60.3%) | -$1.52 M(+17.7%) |
| June 2017 | - | -$668.50 K(+83.7%) | -$1.30 M(+83.3%) |
| Mar 2017 | - | -$364.00 K(+60.9%) | -$706.50 K(+35.2%) |
| Dec 2016 | $33.59 M(-1619.9%) | - | - |
| Dec 2016 | - | -$226.20 K(+518.0%) | -$522.40 K(-38.8%) |
| Sept 2016 | - | -$36.60 K(-54.1%) | -$854.20 K(-35.6%) |
| June 2016 | - | -$79.70 K(-55.7%) | -$1.33 M(-21.2%) |
| Mar 2016 | - | -$179.90 K(-67.8%) | -$1.68 M(-22.3%) |
| Dec 2015 | -$2.21 M(-53.8%) | -$558.00 K(+9.8%) | -$2.17 M(-28.0%) |
| Sept 2015 | - | -$508.00 K(+16.2%) | -$3.01 M(-16.7%) |
| June 2015 | - | -$437.00 K(-34.0%) | -$3.61 M(-17.5%) |
| Mar 2015 | - | -$662.00 K(-52.8%) | -$4.38 M(-8.4%) |
| Dec 2014 | -$4.78 M(-1776.8%) | -$1.40 M(+26.2%) | -$4.78 M(+63.8%) |
| Sept 2014 | - | -$1.11 M(-7.5%) | -$2.92 M(+85.4%) |
| June 2014 | - | -$1.20 M(+12.8%) | -$1.57 M(+451.9%) |
| Mar 2014 | - | -$1.06 M(-331.5%) | -$285.00 K(-200.0%) |
| Dec 2013 | $285.00 K(-106.5%) | $460.00 K(+97.4%) | $285.00 K(-133.9%) |
| Sept 2013 | - | $233.00 K(+167.8%) | -$840.00 K(-36.7%) |
| June 2013 | - | $87.00 K(-117.6%) | -$1.33 M(-22.4%) |
| Mar 2013 | - | -$495.00 K(-25.6%) | -$1.71 M(-61.1%) |
| Dec 2012 | -$4.39 M(-72.8%) | -$665.00 K(+162.8%) | -$4.39 M(-22.3%) |
| Sept 2012 | - | -$253.00 K(-14.2%) | -$5.65 M(-44.4%) |
| June 2012 | - | -$295.00 K(-90.7%) | -$10.16 M(-31.3%) |
| Mar 2012 | - | -$3.18 M(+65.3%) | -$14.79 M(-8.3%) |
| Dec 2011 | -$16.12 M(-6.3%) | -$1.92 M(-59.7%) | -$16.12 M(-5.5%) |
| Sept 2011 | - | -$4.76 M(-3.2%) | -$17.05 M(-2.8%) |
| June 2011 | - | -$4.92 M(+9.1%) | -$17.54 M(+2.1%) |
| Mar 2011 | - | -$4.51 M(+58.1%) | -$17.18 M(-0.2%) |
| Dec 2010 | -$17.20 M(+125.8%) | -$2.85 M(-45.7%) | -$17.20 M(-4.9%) |
| Sept 2010 | - | -$5.26 M(+15.2%) | -$18.08 M(+2.5%) |
| June 2010 | - | -$4.56 M(+0.6%) | -$17.65 M(-8.7%) |
| Mar 2010 | - | -$4.54 M(+21.6%) | -$19.34 M(+153.8%) |
| Dec 2009 | -$7.62 M | -$3.73 M(-22.6%) | -$7.62 M(-23.6%) |
| Sept 2009 | - | -$4.82 M(-22.9%) | -$9.97 M(-23.2%) |
| June 2009 | - | -$6.25 M(-187.0%) | -$12.97 M(-24.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2009 | - | $7.18 M(-218.1%) | -$17.22 M(-57.6%) |
| Dec 2008 | -$40.60 M(-19.6%) | -$6.08 M(-22.3%) | -$40.60 M(-18.6%) |
| Sept 2008 | - | -$7.83 M(-25.4%) | -$49.84 M(-9.1%) |
| June 2008 | - | -$10.49 M(-35.2%) | -$54.81 M(-2.0%) |
| Mar 2008 | - | -$16.20 M(+5.7%) | -$55.90 M(+10.8%) |
| Dec 2007 | -$50.47 M(+102.3%) | -$15.33 M(+19.8%) | -$50.47 M(+14.9%) |
| Sept 2007 | - | -$12.79 M(+10.4%) | -$43.91 M(+6.0%) |
| June 2007 | - | -$11.59 M(+7.6%) | -$41.41 M(+34.7%) |
| Mar 2007 | - | -$10.77 M(+22.8%) | -$30.74 M(+23.2%) |
| Dec 2006 | -$24.95 M(-31.2%) | -$8.77 M(-14.8%) | -$24.95 M(+0.4%) |
| Sept 2006 | - | -$10.29 M(+1025.9%) | -$24.85 M(-4.3%) |
| June 2006 | - | -$914.00 K(-81.7%) | -$25.96 M(-22.7%) |
| Mar 2006 | - | -$4.98 M(-42.5%) | -$33.58 M(-7.4%) |
| Dec 2005 | -$36.24 M(+69.9%) | -$8.67 M(-23.9%) | -$36.24 M(+35.3%) |
| Sept 2005 | - | -$11.40 M(+33.5%) | -$26.79 M(+20.1%) |
| June 2005 | - | -$8.54 M(+11.6%) | -$22.30 M(+9.5%) |
| Mar 2005 | - | -$7.65 M(-1072.9%) | -$20.37 M(-4.5%) |
| Dec 2004 | -$21.33 M(+115.1%) | $786.00 K(-111.4%) | -$21.33 M(-26.7%) |
| Sept 2004 | - | -$6.91 M(+4.6%) | -$29.11 M(+1.5%) |
| June 2004 | - | -$6.60 M(-23.3%) | -$28.67 M(+7.1%) |
| Mar 2004 | - | -$8.61 M(+23.1%) | -$26.77 M(+170.0%) |
| Dec 2003 | -$9.91 M(+11.8%) | -$7.00 M(+8.1%) | -$9.91 M(+16.6%) |
| Sept 2003 | - | -$6.47 M(+37.5%) | -$8.50 M(+58.9%) |
| June 2003 | - | -$4.70 M(-157.0%) | -$5.35 M(+2601.5%) |
| Mar 2003 | - | $8.25 M(-247.8%) | -$198.00 K(-97.8%) |
| Dec 2002 | -$8.87 M(+18.0%) | -$5.58 M(+68.4%) | -$8.87 M(+37.1%) |
| Sept 2002 | - | -$3.31 M(-841.6%) | -$6.47 M(+61.9%) |
| June 2002 | - | $447.00 K(-207.2%) | -$4.00 M(-37.1%) |
| Mar 2002 | - | -$417.00 K(-86.9%) | -$6.35 M(-15.5%) |
| Dec 2001 | -$7.51 M(-11.2%) | -$3.18 M(+276.9%) | -$7.51 M(+25.7%) |
| Sept 2001 | - | -$844.00 K(-55.7%) | -$5.97 M(-14.6%) |
| June 2001 | - | -$1.91 M(+20.6%) | -$7.00 M(+14.4%) |
| Mar 2001 | - | -$1.58 M(-3.8%) | -$6.12 M(-27.6%) |
| Dec 2000 | -$8.46 M(+1.9%) | -$1.64 M(-12.0%) | -$8.46 M(-14.7%) |
| Sept 2000 | - | -$1.87 M(+82.5%) | -$9.91 M(-2.3%) |
| June 2000 | - | -$1.02 M(-73.9%) | -$10.14 M(-7.1%) |
| Mar 2000 | - | -$3.92 M(+26.4%) | -$10.92 M(+31.5%) |
| Dec 1999 | -$8.30 M(+159.4%) | -$3.10 M(+47.6%) | -$8.30 M(+38.3%) |
| Sept 1999 | - | -$2.10 M(+16.7%) | -$6.00 M(+46.3%) |
| June 1999 | - | -$1.80 M(+38.5%) | -$4.10 M(+46.4%) |
| Mar 1999 | - | -$1.30 M(+62.5%) | -$2.80 M(-12.5%) |
| Dec 1998 | -$3.20 M(-15.8%) | -$800.00 K(+300.0%) | -$3.20 M(-3.0%) |
| Sept 1998 | - | -$200.00 K(-60.0%) | -$3.30 M(-23.3%) |
| June 1998 | - | -$500.00 K(-70.6%) | -$4.30 M(-10.4%) |
| Mar 1998 | - | -$1.70 M(+88.9%) | -$4.80 M(+26.3%) |
| Dec 1997 | -$3.80 M(+442.9%) | -$900.00 K(-25.0%) | -$3.80 M(+31.0%) |
| Sept 1997 | - | -$1.20 M(+20.0%) | -$2.90 M(+26.1%) |
| June 1997 | - | -$1.00 M(+42.9%) | -$2.30 M(+130.0%) |
| Mar 1997 | - | -$700.00 K(+16.7%) | -$1.00 M(+66.7%) |
| Dec 1996 | -$700.00 K(<-9900.0%) | - | - |
| Sept 1996 | - | -$600.00 K(-300.0%) | -$600.00 K(<-9900.0%) |
| June 1996 | $0.00(0.0%) | $300.00 K(-400.0%) | $0.00(-100.0%) |
| Mar 1996 | - | -$100.00 K(-50.0%) | -$300.00 K(+50.0%) |
| Dec 1995 | - | -$200.00 K(<-9900.0%) | -$200.00 K(<-9900.0%) |
| Sept 1995 | - | $0.00(0.0%) | $0.00(-100.0%) |
| June 1995 | $0.00(-100.0%) | $0.00(0.0%) | $100.00 K(0.0%) |
| Mar 1995 | - | $0.00(0.0%) | $100.00 K(-200.0%) |
| Dec 1994 | - | $0.00(-100.0%) | -$100.00 K(-200.0%) |
| Sept 1994 | - | $100.00 K(>+9900.0%) | $100.00 K(0.0%) |
| June 1994 | $100.00 K | $0.00(-100.0%) | $100.00 K(0.0%) |
| Mar 1994 | - | -$200.00 K(-200.0%) | $100.00 K(-66.7%) |
| Dec 1993 | - | $200.00 K(+100.0%) | $300.00 K(+200.0%) |
| Sept 1993 | - | $100.00 K | $100.00 K |
FAQ
- What is Moderna annual free cash flow?
- What is the all time high annual FCF for Moderna?
- What is Moderna annual FCF year-on-year change?
- What is Moderna quarterly free cash flow?
- What is the all time high quarterly FCF for Moderna?
- What is Moderna quarterly FCF year-on-year change?
- What is Moderna TTM free cash flow?
- What is the all time high TTM FCF for Moderna?
- What is Moderna TTM FCF year-on-year change?
What is Moderna annual free cash flow?
The current annual FCF of MRNA is -$3.83 B
What is the all time high annual FCF for Moderna?
Moderna all-time high annual free cash flow is $13.34 B
What is Moderna annual FCF year-on-year change?
Over the past year, MRNA annual free cash flow has changed by -$8.41 B (-183.50%)
What is Moderna quarterly free cash flow?
The current quarterly FCF of MRNA is -$1.72 B
What is the all time high quarterly FCF for Moderna?
Moderna all-time high quarterly free cash flow is $4.03 B
What is Moderna quarterly FCF year-on-year change?
Over the past year, MRNA quarterly free cash flow has changed by +$23.00 M (+1.32%)
What is Moderna TTM free cash flow?
The current TTM FCF of MRNA is -$3.96 B
What is the all time high TTM FCF for Moderna?
Moderna all-time high TTM free cash flow is $13.34 B
What is Moderna TTM FCF year-on-year change?
Over the past year, MRNA TTM free cash flow has changed by -$1.30 B (-48.89%)